Global Arterial Vascular Stents Market Size By Type (Self Expansion, Balloon Dilatation), By Application (Hospitals And Cardiac Centers, Ambulatory Surgical Centers), By Region, And Segment Forecasts,...

The Global Arterial Vascular Stents Market was valued at USD 14.3 billion in 2023 and is projected to reach USD 25.6 billion by 2031, expanding at a CAGR of 7.6% during the forecast period of 2023–2031. This market growth is driven by the increasing prevalence of cardiovascular diseases, rising geriatric population, and continuous advancements in stent technologies. Arterial vascular stents play a vital role in treating atherosclerosis, peripheral artery disease (PAD), and coronary artery disease (CAD), offering minimally invasive solutions to restore and maintain blood flow. With the global burden of heart disease rising, the demand for effective, safe, and long-lasting stenting solutions is accelerating.

Drivers:

1. Rising Prevalence of Cardiovascular Diseases:

The growing incidence of conditions such as coronary artery disease and peripheral artery disease is significantly boosting the demand for arterial vascular stents. Factors such as sedentary lifestyles, obesity, and smoking further contribute to the increase in cardiovascular cases globally.

2. Advancements in Stent Technologies:

The evolution from bare-metal stents to drug-eluting and bioresorbable stents has enhanced the safety and efficacy of treatments. Innovations aimed at improving biocompatibility, reducing restenosis, and enhancing delivery systems are fueling market expansion.

3. Aging Population:

A globally increasing aging demographic, particularly in developed nations, is more susceptible to vascular conditions. This demographic shift is directly contributing to the demand for vascular stents.

Restraints:

1. High Cost of Advanced Stents:

The adoption of next-generation stents comes with high costs, which may be prohibitive for healthcare systems in low- and middle-income countries. This cost factor can limit the accessibility of advanced treatments to certain populations.

2. Risks Associated with Stent Placement:

Despite being minimally invasive, stent procedures carry risks such as blood clots, infection, and in-stent restenosis. Concerns around post-operative complications can hinder the adoption of vascular stenting, especially in critical cases.

Opportunity:

1. Expanding Healthcare Infrastructure in Emerging Markets:

Rapid urbanization and increased healthcare spending in countries like India, China, and Brazil are creating lucrative opportunities for market players. Government-led initiatives to combat heart diseases are further supporting market penetration.

2. Development of Biodegradable and Smart Stents:

The emergence of fully bioresorbable stents and smart, sensor-enabled stents for real-time monitoring offer tremendous future potential. These innovations can lead to enhanced patient outcomes and open new commercial pathways.

Market by System Type Insights:

Based on system type, Drug-Eluting Stents (DES) held the largest market share in 2023. These stents release medication to prevent restenosis, offering better long-term outcomes compared to bare-metal stents. With increasing physician preference and proven clinical benefits, DES is expected to retain dominance throughout the forecast period. Meanwhile, Bioresorbable Vascular Scaffolds (BVS) are gaining traction due to their potential to reduce long-term complications, positioning them as the fastest-growing segment.

Market by End-use Insights:

Hospitals remained the primary end-use segment in 2023, accounting for over 60% of global revenue. The availability of advanced surgical facilities, skilled interventional cardiologists, and access to a broad patient base drive this segment. Ambulatory Surgical Centers (ASCs) are also emerging as a key end-user due to shorter procedure times, lower costs, and faster patient recovery, making them a preferred choice in developed markets.

Market by Regional Insights:

North America led the global arterial vascular stents market in 2023, underpinned by a high burden of cardiovascular disease, favorable reimbursement frameworks, and strong presence of market leaders. However, the Asia-Pacific region is projected to exhibit the fastest CAGR through 2031. Increasing awareness, rising healthcare expenditures, and strategic investments in cardiac care infrastructure are propelling growth in the region.

Competitive Scenario:

Key players in the global arterial vascular stents market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Cook Medical Inc., MicroPort Scientific Corporation, and Lepu Medical Technology. These companies are leveraging technological innovation, strategic collaborations, and global expansion to stay competitive.

In 2023, Abbott Laboratories launched a next-generation drug-eluting stent with enhanced deliverability for complex cases.

Boston Scientific announced a partnership in 2024 to expand its biodegradable stent portfolio in Asia.

In 2025, Medtronic received regulatory approval in Europe for its AI-integrated stent monitoring system.

Scope of Work – Global Arterial Vascular Stents Market

Report Metric Details

Market Size (2023) USD 14.3 billion

Projected Market Size (2031) USD 25.6 billion

CAGR (2023–2031) 7.6%

Market Segments By System Type (Bare-Metal, Drug-Eluting, Bioresorbable), By End-use (Hospitals, ASCs, Others), By Region

Growth Drivers Rising cardiovascular disease burden, Aging population, Advancements in stent technology

Opportunities Emerging markets, Development of bioresorbable and smart stents

Key Market Developments:

2023: Abbott launched the Xience Sierra stent in global markets, focusing on small vessel and complex lesion management.

2024: Boston Scientific expanded its operations in Southeast Asia to improve access to its drug-eluting stents.

2025: Medtronic introduced a smart stent platform integrated with remote monitoring capabilities to enhance post-operative care.

FAQs:

1. What is the current market size of the Global Arterial Vascular Stents Market?

The market was valued at USD 14.3 billion in 2023.

2. What is the major growth driver of the Global Arterial Vascular Stents Market?

The major growth driver is the rising prevalence of cardiovascular diseases and advancements in stent technology.

3. Which is the largest region during the forecast period in the Global Arterial Vascular Stents Market?

North America holds the largest market share due to advanced healthcare infrastructure and high disease burden.

4. Which segment accounted for the largest market share in the Global Arterial Vascular Stents Market?

The Drug-Eluting Stents (DES) segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Arterial Vascular Stents Market?

Key players include Medtronic, Abbott, Boston Scientific, Terumo, Biotronik, and B. Braun.